NOTICE OF INTENT TO SOLE SOURCE - Blood Bank Reagent testing supplies/equipment at BJACH
Closed Special Notice Posted
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- Fort Johnson, Louisiana 71459, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Army Medical Command (MEDCOM) has issued a Special Notice for a sole source supply contract to provide Blood Bank Reagent testing supplies, including equipment, maintenance, and support, for the Bayne Jones Army Community Hospital (BJACH) in Fort Johnson, Louisiana. The proposed contract will be awarded to Ortho-Clinical Diagnostics, Inc. (CAGE Code: 1C0L5) for the period of October 1, 2024 to September 30, 2025.
The purpose of this sole source contract is to provide a fully automated, discrete random-access analyzer system capable of performing all required blood bank testing services, including ABORh, antibody screen, direct antiglobulin, and crossmatches. The contractor will be responsible for furnishing the testing instruments, reagents, consumables, maintenance, and support at no extra cost to the government. The requirement falls under NAICS code 325413, In-Vitro Diagnostic Substance Manufacturing, with a small business size standard of 1,250 employees. Interested vendors are requested to respond to this notice no later than 1300 hours CST on or before July 3, 2024.
Notice text
NOTICE OF INTENT TO SOLE SOURCE AND SYNOPSIS
The U.S. Government, Medical Readiness Contracting Office - West, JBSA - Fort Sam Houston, Texas intends to award a supply contract to provide Blood Bank Reagent testing supplies (including equipment, maintenance, and support at no extra cost to the government) located at Fort Johnson, LA used in support of the Pathology testing mission at Bayne Jones Army Community Hospital (BJACH) due to the MHS Genesis Network backlog delay. Ordering Period is from 01 October 2024 to 30 September 2025.
The proposed contract number will be awarded on a sole source Firm-Fixed Price (FFP) action to:
Ortho-Clinical Diagnostics, Inc. (CAGE Code: 1C0L5)
1001 Us Highway 202
Raritan, New Jersey
08869-1424, United States
Synopsis Description of Supplies: The contractor shall provide Blood Bank Reagent testing supplies (including equipment, maintenance, and support at no extra cost to the government) located at Fort Johnson, LA. The blood bank testing instruments, reagents and consumables will provide a fully automated, discrete random-access analyzer system capable of performing all required systems and services necessary. The Contractor shall be responsible for furnishing automated transfusion analyzer systems and independent workstation (inclusive of instruments, ancillary equipment, maintenance, services, repairs, support, parts as required to maintain the systems in optimal operating condition, and any installation and removal, at no extra cost to the Government). The Contractor shall perform to the standards of IAW the Statement of Work (SOW). The clinical tests provided by this instrument will help provide appropriate patient care, avoid unnecessary costs, and delays in diagnosis.
The North American Industrial Classification System (NAICS) Code that best fits this requirement is– 325413, In-Vitro Diagnostic Substance Manufacturing. The NAICS code selected best fits FSC 6550 – In-Vitro Diagnostic Substances, Reagents, Test Kits, and Sets. Small Business Size Standard: 1,250 employees.
This sole source requirement is issued under the statutory authority of FAR 13.106-1(b)(1): FAR 13.106-1(b)(1): For purchases not exceeding the simplified acquisition threshold (SAT), only one source reasonably available, urgency, exclusive licensing agreements, brand name, or industrial mobilization. Please see attached redacted Single Source Justification for further details.
This notice does not constitute a Request for Quote (RFQ)/Invitation for Bid (IFB)/Request for Proposal (RFP) or a promise to issue an RFQ, IFB or RFP in the future. The U.S. Government will not pay for any information or administrative costs incurred in response to this notice. The Government intends to acquire a commercial item using FAR Part 12 and intends to procure from only one source under the authority of FAR 13.106-1(b)(1), that the circumstances of this contract action deem only a sole source is reasonably available to fulfill the stated requirement.
The notice of intent is not a request for competitive proposals. This sole source synopsis is for informational purposes only.
NOTE: INTERESTED VENDORS, PLEASE RESPOND TO THIS NOTICE NO LATER THAN 1300 HOURS CST ON OR BEFORE 03 JULY 2024.
Files
| File | Type | Posted |
|---|---|---|
| Draft Statement of Work.pdf | ||
| Sole Source Justification-Redacted.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Sole Source Notice - Blood and Blood Products | Department of Veterans Affairs | No set-aside | |
| 6550--Blood Bank Reagents | Veterans Integrated Service Network 17 | No set-aside | |
| 6505--Human Blood and Blood Products | Veterans Integrated Service Network 17 | No set-aside | |
| 6550--Blood Type IVD Reagents | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity